Oncocyte Corporation (OCX) SEC filings
OCX SEC filings moved a median of -0.43% by the close. OCX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the OCX overview →
48 measured OCX SEC filing events.
Where these OCX SEC filings landedvs 48 measured OCX SEC filing reactions
| Middle 50% of OCX SEC filing reactions | -2.00% to +4.35% |
|---|---|
| Median reaction (to close) | -0.43% |
| Measured reactions | 48 |
Point-in-time · zero look-ahead
Half of the 48 OCX SEC filing events with a measured close landed between -2.00% and +4.35%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Oncocyte Corp For: Jun 13 | SEC filing · Form 8-K | -2.17% | +15.52% | |
| Form ARS Oncocyte Corp For: Dec 31 | SEC filing · Form ARS | +0.00% | +7.31% | |
| Form DEF 14A Oncocyte Corp For: May 14 | SEC filing · Form DEF | +0.00% | +7.31% | |
| Form DEFA14A Oncocyte Corp | SEC filing · Form DEFA14A | +0.00% | +7.31% | |
| Form 10-Q Oncocyte Corp For: Mar 31 | SEC filing · Form 10-Q | -0.35% | -1.77% | |
| Form 8-K Oncocyte Corp For: May 12 | SEC filing · Form 8-K | -0.35% | -1.77% | |
| Form 8-K Oncocyte Corp For: Apr 11 | SEC filing · Form 8-K | +1.06% | +1.77% | |
| Form EFFECT Oncocyte Corp | SEC filing · Form EFFECT | -8.80% | -13.52% | |
| Form S-1 Oncocyte Corp | SEC filing · Form S-1 | — | -0.97% | |
| Form 10-K Oncocyte Corp For: Dec 31 | SEC filing · Form 10-K | -6.04% | -16.48% | |
| Form 8-K Oncocyte Corp For: Mar 24 | SEC filing · Form 8-K | -6.04% | -16.48% | |
| Form 8-K Oncocyte Corp For: Mar 04 | SEC filing · Form 8-K | +3.25% | -1.68% | |
| Form D Oncocyte Corp | SEC filing · Form D | +0.00% | -0.76% | |
| Form 8-K Oncocyte Corp For: Feb 06 | SEC filing · Form 8-K | -1.48% | +1.97% | |
| Form 8-K Oncocyte Corp For: Jan 02 | SEC filing · Form 8-K | — | -0.45% | |
| Form 10-Q Oncocyte Corp For: Sep 30 | SEC filing · Form 10-Q | -1.67% | -2.00% | |
| Form 8-K Oncocyte Corp For: Nov 12 | SEC filing · Form 8-K | -1.67% | -2.00% | |
| Form EFFECT Oncocyte Corp | SEC filing · Form EFFECT | — | +0.65% | |
| Form S-3/A Oncocyte Corp | SEC filing · Form S-3 | -1.73% | -2.50% | |
| Form S-3 Oncocyte Corp | SEC filing · Form S-3 | +2.31% | +2.97% | |
| Form 8-K Oncocyte Corp For: Oct 11 | SEC filing · Form 8-K | +0.00% | -4.60% | |
| Form D Oncocyte Corp | SEC filing · Form D | -2.89% | -1.29% | |
| Form 8-K Oncocyte Corp For: Oct 02 | SEC filing · Form 8-K | +0.00% | -6.29% | |
| Form DEF 14A Oncocyte Corp For: Sep 25 | SEC filing · Form DEF | — | +2.41% | |
| Form 8-K Oncocyte Corp For: Aug 09 | SEC filing · Form 8-K | — | +4.35% | |
| Form EFFECT Oncocyte Corp | SEC filing · Form EFFECT | — | +4.35% | |
| Form 10-Q Oncocyte Corp For: Jun 30 | SEC filing · Form 10-Q | — | +4.35% | |
| Form 8-K Oncocyte Corp For: Aug 08 | SEC filing · Form 8-K | — | +4.35% | |
| Form S-3 Oncocyte Corp | SEC filing · Form S-3 | +0.00% | -0.64% | |
| Form 8-K Oncocyte Corp For: Jul 08 | SEC filing · Form 8-K | +0.00% | -1.75% | |
| Form 8-K Oncocyte Corp For: Jun 28 | SEC filing · Form 8-K | +0.00% | +1.35% | |
| Form 8-K Oncocyte Corp For: Jun 17 | SEC filing · Form 8-K | +0.00% | -3.24% | |
| Form 8-K Oncocyte Corp For: May 30 | SEC filing · Form 8-K | +0.00% | -2.88% | |
| Form 8-K Oncocyte Corp For: May 20 | SEC filing · Form 8-K | — | -0.70% | |
| Form EFFECT Oncocyte Corp | SEC filing · Form EFFECT | +0.00% | +1.59% | |
| Form S-3/A Oncocyte Corp | SEC filing · Form S-3 | -5.51% | -4.83% | |
| Form 10-Q Oncocyte Corp For: Mar 31 | SEC filing · Form 10-Q | +2.22% | +13.70% | |
| Form 8-K Oncocyte Corp For: May 15 | SEC filing · Form 8-K | +2.22% | +13.70% | |
| Form S-3 Oncocyte Corp | SEC filing · Form S-3 | — | -0.52% | |
| Form DEF 14A Oncocyte Corp For: Apr 29 | SEC filing · Form DEF | -0.40% | +0.00% | |
| Form D Oncocyte Corp | SEC filing · Form D | +1.63% | -0.41% | |
| Form 10-K Oncocyte Corp For: Dec 31 | SEC filing · Form 10-K | -0.13% | +7.42% | |
| Form 8-K Oncocyte Corp For: Apr 11 | SEC filing · Form 8-K | -5.63% | -15.31% | |
| Form 8-K Oncocyte Corp For: Apr 05 | SEC filing · Form 8-K | -5.63% | -15.31% | |
| Form NT 10-K Oncocyte Corp For: Dec 31 | SEC filing · Form NT | — | +2.81% | |
| Form 8-K Oncocyte Corp For: Jan 22 | SEC filing · Form 8-K | — | -0.30% | |
| Form 10-Q Oncocyte Corp For: Sep 30 | SEC filing · Form 10-Q | +1.15% | +6.11% | |
| Form 8-K Oncocyte Corp For: Nov 09 | SEC filing · Form 8-K | +4.58% | +12.42% |
Keep exploring
More OCX: earnings → · analyst actions → · OCX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| G1 Therapeutics, Inc. (GTHX) | 142 | +0.21% | 66% |
| InflaRx N.V. (IFRX) | 142 | 0.00% | 48% |
| ImmunoGen, Inc. (IMGN) | 140 | +0.07% | 56% |
| MEDIFIRST SOLUTIONS (MFST) | 140 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.